ui.skipToMain
Comercializadora de Servicios Médicos Cubanos, S.A.SMC Salud
NeuroEPO research, intensive cognitive rehabilitation at CIREN, and comprehensive clinical evaluation

Alzheimer's & Dementia Care in Cuba for U.S. Patients

Over 7.4 million Americans age 65+ are living with Alzheimer's dementia. Cuba offers a fundamentally different approach — NeuroEPO neuroprotective research, 4–6 hours of daily multidisciplinary cognitive rehabilitation at CIREN, and mandatory caregiver training. For American families exploring international treatment options.

Alzheimer's & Dementia treatment in Cuba for U.S. patients

Clinical Research Basis

Patient Safety First

Expert Medical Teams

International Standards

Alzheimer's & Dementia — Treatment Topics

Explore Alzheimer's & Dementia Treatment Options

Each topic below provides in-depth information about Cuba's alzheimer's & dementia treatment approach, with state-specific pages for 10 high-priority U.S. states.

State-by-State Guide

Alzheimer's & Dementia by U.S. State

We've prioritized the 10 U.S. states with the highest Alzheimer's rates. Each state page includes local statistics, travel logistics, and state-specific context.

Frequently Asked Questions

Questions from American Families

Yes. U.S. citizens can travel to Cuba under approved categories. SMC Salud provides all necessary documentation, including the letter of medical necessity and treatment confirmation, to support travel authorization. Our team guides you through the entire process to ensure compliance with all regulations.

Ready to Explore Alzheimer's & Dementia Treatment in Cuba?

Submit your medical records for a complimentary review by Cuba's medical team. Receive a personalized treatment proposal within 5–10 business days — no obligation to travel.